Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer - Wikidata - wikimedia - TriplyDB

Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer

Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer

http://www.wikidata.org/entity/Q34977651

about

Update in lung cancer and mesothelioma 2012 The relationship between tumor volume changes and serial plasma osteopontin detection during radical radiotherapy of non-small-cell lung cancer.Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer.Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib.The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy An observational study of circulating tumor cells and (18)F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer.Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapy.A new PET/CT volumetric prognostic index for non-small cell lung cancer Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma Baseline tumour measurements predict survival in advanced non-small cell lung cancer.Incorporating prognostic imaging biomarkers into clinical practice.Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.Modern diagnostic and therapeutic interventional radiology in lung cancer.PET/CT in therapy evaluation of patients with lung cancer.The role of PET/CT as a prognosticator and outcome predictor in lung cancer.Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer.Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma.Metabolic tumor burden quantified on [18F]FDG PET/CT improves TNM staging of lung cancer patients.Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer.

P2860

Q24619675-7560CFCB-5966-4768-8D51-003C37559905 Q30313659-C306BB3F-44DC-49C9-88A4-C5866DB1F5CF Q33704656-32C0AA9F-4E6E-4E75-9237-310987C1EE24 Q34163370-0FC71355-0CFA-40D0-B85A-22709E7CA563 Q34720945-86AB0283-DEF3-4913-862F-B0FC4AD30217 Q34826007-BAE00FCF-B00B-4A5E-9476-85D74B9338AF Q35213015-05E995D5-41ED-4696-B77D-06C62356E2F3 Q35688617-C5B23E92-78DD-435C-BAA0-357E4EB5C74F Q36304366-1A9F36D5-99DC-48A4-9447-DD7E23EC6E32 Q36490370-BA67EF33-270E-43C7-9D99-67A88CE16577 Q36516767-15F3C4D1-9292-4F16-A919-78346D431B6B Q36655475-59C5CFFF-CD3E-4904-AFB9-592C5A58A4E8 Q37182213-D1584EFE-775A-4A5A-B117-3E5435331725 Q37193816-6E9D8CD0-412B-4EE4-B2D5-65EC94A426C0 Q38014317-865F60D3-F23E-45E6-B783-D76C22187799 Q38155852-88F78445-9610-4AE6-A9E4-96FDC594EA37 Q38202189-EA85EC14-6049-4827-816C-5ED9921F3606 Q38715401-A6671249-91CE-4035-A724-3F5C378D9464 Q38841400-06839F57-5E14-4F09-AF25-AFC120E6D75C Q38934437-E4E168F2-E019-472F-A43C-952F155428DB Q39127172-0074C63E-274D-40D7-8C8E-68C5A9E25D35 Q39373649-67D83C3D-FAA7-4379-A89C-25FC1F4338D2 Q40780999-8470CA40-7FFF-4F1A-8628-CC9C20EBE60E Q42232269-7441D56F-5923-4750-A443-48E255B9A1BA Q45349782-904F9A24-54C9-40E3-BB36-6E201EB0219D Q45970133-7F342734-12A7-42FD-BD7A-5DBDFAF99748 Q47735250-AE901CA6-D6C3-412B-9DF1-3A2DC2C7A5AB Q49147470-094C14A5-52F7-4479-9385-0C541BAF703B Q53095046-4932F595-9B11-46A4-AB2E-931E2F1624DF Q53327726-2031FC48-5BDF-4224-9320-563651BAC889

P2860

Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer

http://www.wikidata.org/entity/Q34977651

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@ast

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@en

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@nl

type

label

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@ast

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@en

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@nl

prefLabel

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@ast

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@en

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@nl

P1433

Q34977651-AEA617DF-9939-48B3-BB52-4051A54FE431

P1476

Q34977651-CCB67BB4-7CDA-43A0-83DA-9140C2CCB2F4

P2093

Q34977651-0AC54D08-A0C8-43FD-A9AE-9652136C15AC

Q34977651-1A2A24BF-A470-4C66-A2E3-CE3ACDE9F53A

Q34977651-1BD2C88C-9189-4633-8D12-51281AE7B04C

Q34977651-2EB4949B-6B0F-4900-8FC3-A8E66D2CEC1D

Q34977651-8C69994F-581D-4C99-948F-D70D0B9207EB

Q34977651-A07CAF35-F308-495E-9EBF-FB31BAEDFD98

Q34977651-AAA0CA91-1AD7-4C0F-94D1-D324A94BCA30

Q34977651-E0F83E7C-7EFC-4C3E-94C0-B75E98A03523

Q34977651-F83F9329-74A6-431E-A706-E554B66E6769

P2860

Q34977651-17553297-F094-4A72-8459-54138B408E3C

Q34977651-1FE69DD8-C9AD-451A-9D6B-A0C61CBA78BB

Q34977651-2A939265-786A-485B-B124-DEE696A37DFE

Q34977651-2BD4823C-F319-45BA-944E-E7D16326BB78

Q34977651-3C49A1E4-1CEC-4B8C-8C3B-C6AD5C27FB92

Q34977651-48CE0D8A-7E48-48FE-A61B-B05F6483B3D5

Q34977651-75078EF8-B161-47ED-BBDD-50521D808CBB

Q34977651-83CA0DA3-8D0F-40BC-9471-858D7C9B74AC

Q34977651-9B6160C9-3D14-4D6C-B2AD-5D8D7892B55B

Q34977651-9C0C887A-B275-4AC6-95EF-4F86B2FB8929

P304

Q34977651-76D9F50B-49C3-414A-AA4A-70A67C5F08D6

P31

Q34977651-E847BA72-F170-48A7-A460-4196B313ADF1

P356

Q34977651-7C12DD6A-480B-4272-8FD0-7B33A4E29522

P407

Q34977651-D5C3D2C1-451E-4872-8711-B6324D436340

P433

Q34977651-AAEFAA4F-3FF3-496C-94FA-F5748D522931

P478

Q34977651-478A6375-B520-486D-8235-A6A4434FBBAE

P577

Q34977651-50985C16-CCF9-4F2F-A362-665C4020D5DF

P698

Q34977651-208138F2-D55E-4FB2-B06A-7D5B92D5F008

P921

Q34977651-50C67E8A-A504-4735-97DA-164DE4B23143

P932

Q34977651-ED5D738F-F4D5-404C-A2A5-D5C8BE5E7EA1

P356

J.CLLC.2011.05.001

P1433

Clinical Lung Cancer

P1476

Metabolic tumor volume is an i ...... for non-small-cell lung cancer

@en

P2093

Andrew Quon

http://www.w3.org/2001/XMLSchema#string

Billy W Loo

http://www.w3.org/2001/XMLSchema#string

Dilani K Weerasuriya

http://www.w3.org/2001/XMLSchema#string

Edward E Graves

http://www.w3.org/2001/XMLSchema#string

Heather A Wakelee

http://www.w3.org/2001/XMLSchema#string

Jose G Bazan

http://www.w3.org/2001/XMLSchema#string

Percy Lee

http://www.w3.org/2001/XMLSchema#string

Philip W Lavori

http://www.w3.org/2001/XMLSchema#string

Quynh-Thu Le

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Cancer statistics, 2009

Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.

Prognostic factors in non-small cell lung cancer: a decade of progress.

Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

RT_Image: an open-source tool for investigating PET in radiation oncology.

Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy.

Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.

P304

52-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLLC.2011.05.001

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21703935

http://www.w3.org/2001/XMLSchema#string

P921

P932

4296977

http://www.w3.org/2001/XMLSchema#string